The sensors, which help to provide continuous temperature readings to monitor patients are being used by the Shanghai Public Health Clinical Center.
VivaLNK, a leading provider of connected healthcare solutions, created a continuous temperature sensor which is helping to combat the spread of the disease in China. Created after the previous SARS outbreak the Shanghai Public Health Clinical Center (SPHCC) contains specialised wards that are designed to limit cross infection and to provide more efficient treatments.
The treatment centre has been designated as the primary centre in Shanghai after the coronavirus outbreak. Confirmed patients from area hospitals are also sent to the SPHCC for quarantine and treatment. One of the key challenges when it comes to combatting contagious diseases is limiting the spread of the virus within hospitals.
Cross infection from patient-to-patient and patient-to-caregiver can be a very serious problem. While quarantining patients may limit patient-to-patient contact, contact between caregivers and patients can also be avoided with technology.
The VivaLNK temperature sensor has clearances from the CFDA, FDA, and CE, and is part of VivaLNK’s medical wearable platform which includes sensors to monitor a variety of other vitals and biometrics.
The temperature sensor is applied directly onto the patient and allows for continuous, real-time monitoring of changes in body temperature. The data collected is then sent electronically from the patient to a remote observation dashboard at the nursing station, providing a view of the patients. This now means that instead of physically checking the patient’s temperature every few hours with a mercury thermometer, temperatures can be monitored remotely and automatically, thereby limiting patient-to-caregiver contact.
Jiang Li, CEO of VivaLNK, said: “VivaLNK is proud to help fight infectious diseases such as the Coronavirus. The world will never be rid of diseases, but more effective methods of prevention and treatment can be achieved through technological advances.”